Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14081569 | 0.84 | TSHR (0.51) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL19901389 | 0.82 | TSHR (0.78) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL13416441 | 0.81 | GAA (0.44) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL3196336 | 0.81 | MEN1 (0.63) | TSHRALDH1A1MAPTUSP2SMN1; SMN2 | |
| SCHEMBL29625376 | 0.81 | MEN1 (0.63) | TSHRALDH1A1MAPTUSP2SMN1; SMN2 | |
| SCHEMBL10014710 | 0.80 | USP2 (0.76) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL3199627 | 0.79 | SMN1; SMN2 (0.58) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL5922720 | 0.79 | SMN1; SMN2 (0.58) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL12599337 | 0.79 | USP2 (0.65) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL13416447 | 0.78 | GAA (0.41) | TSHRCYP3A4CYP2C19NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2018-01-11 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-9315633-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-9315633-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-20160060377-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060400-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060377-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20160060400-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | PARN, AADAC, PARG | TSHR 4243/4885CYP3A4 3104/4885CYP2C19 2009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.